Skip to content
TrackPodcasts
newsMar 23, 20261:21

Ocasio-Cortez Campaign Spent $19K on Ketamine Therapy

About this episode

Rep. Alexandria Ocasio-Cortezs campaign spent nearly $19,000 on ketamine therapy services from a Boston psychiatrist, raising ethical concerns and sparking debates on the safety and funding of cutting-edge mental health treatments.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/82dcd959b181e305

Get every episode summarized

Each time US News Today | 2 Min News | The Daily News Now! publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

Transcript ready

16 searchable segments. Every word is indexed and playable.

Ocasio-Cortez Campaign Spent $19K on Ketamine Therapy

US News Today | 2 Min News | The Daily News Now!

0:00
1:21

Full transcript

US News Today | 2 Min News | The Daily News Now!Ocasio-Cortez Campaign Spent $19K on Ketamine Therapy. Machine-transcribed; use the interactive transcript above to jump the player to any line.

On March 23rd, Repay, Alexandria, Ocasio, Cortez's campaign spent nearly $19,000 last year on services from a Boston psychiatrist, specializing in ketamine therapy. Federal Election Commission records show payments totaling $18,725 to Dr. Brian Boyle, listed as, leadership training and consulting. Those payments broke down to $11,550 in March, $2,800 in May, and $4,375 in October. Boyle works with Stella Clinics, which provide ketamine treatments for issues like depression, post-traumatic stress disorder, and anxiety. The exact services and who benefit it remain unclear, drawing fire from ethics advocates who question the use of campaign money. Meanwhile, Ocasio Cortez has pushed for more research on psychedelics, co-sponsoring bills to ease restrictions on substances like psilocybin and MDMA, with one passing in 2023.

Ketamine, once mainly an anesthetic, is getting attention for mental health potential, but faces scrutiny after actor Matthew Perry's death in 20, 23 while undergoing the therapy. Medical experts warn it needs strict oversight due to risks. This case spotlights how campaigns tap into cutting-edge treatments, even as debates grow over their safety and funding.

More episodes

More from US News Today | 2 Min News | The Daily News Now!

View all episodes →